Eradication of early MRSA infection in cystic fibrosis: a novel study design for the STAR-ter trial by Fiona Cunningham, Ellen Caldwell, Nicole Mayer-Hamblett, Christopher H. Goss, Marianne S. Muhlebach

Get full text

Evaluation of microbial bacterial and fungal diversity in cerebrospinal fluid shunt infection. by Tamara D Simon, Christopher E Pope, Samuel R Browd, Jeffrey G Ojemann, Jay Riva-Cambrin, Nicole Mayer-Hamblett, Margaret Rosenfeld, Danielle M Zerr, Lucas Hoffman

Get full text

Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design by Amalia Magaret, Nicole Mayer-Hamblett, Jill M VanDalfsen, Raksha Jain, Phuong T Vu, Ashley Keller, Alexandra Wilson, Melissa S Putman, Jennifer L Taylor-Cousar, Charles R Esther

Get full text

Limited effects of azithromycin on the oropharyngeal microbiome in children with CF and early pseudomonas infection by Brandie D. Wagner, Edith T. Zemanick, Scott D. Sagel, Charles E. Robertson, Mark J. Stevens, Nicole Mayer-Hamblett, George Retsch-Bogart, Bonnie W. Ramsey, J. Kirk Harris

Get full text

LasR Variant Cystic Fibrosis Isolates Reveal an Adaptable Quorum-Sensing Hierarchy in <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content> by John B. Feltner, Daniel J. Wolter, Christopher E. Pope, Marie-Christine Groleau, Nicole E. Smalley, E. Peter Greenberg, Nicole Mayer-Hamblett, Jane Burns, Eric Déziel, Lucas R. Hoffman, Ajai A. Dandekar

Get full text